Manufacturing, Packaging, Labelling and Distribution of The Investigational Medicinal Product (Imp) for The Option-dm Trial (optimal Pathway for Treating Neuropathic Pain in Diabetes Mellitus Trial).

Text to be corrected in the original notice: Place of text to be modified: Time limit for receipt of tenders or requiests to participate Instead of: Closing at 12 noon on 3rd October 2016 Read: Closing at 5.00 pm on 4th October 2016 Packaging and related services.